Lenalidomide-based induction and maintenance in elderly newly diagnosed multiple myeloma patients: updated results of the EMN01 randomized trial

Lenalidomide-based induction and maintenance in elderly newly diagnosed multiple myeloma patients: updated results of the EMN01 randomized trial

Bringhen S;D'Agostino M;Paris L;Ballanti S;Pescosta N;Spada S;Pezzatti S;Grasso M;Rota-Scalabrini D;De Rosa L;Pavone V;Gazzera G;Aquino S;Poggiu M;Santoro A;Gentile M;Baldini L;Petrucci MT;Tosi P;Marasca R;Cellini C;Palumbo A;Falco P;Hájek R;Boccadoro M;Larocca A;;
Haematologica 2020 Vol. 105 pp. -
230
s2020haematologicalenalidomide-based

Abstract

n the EMN01 trial, the addition of an alkylator (melphalan or cyclophosphamide) to lenalidomide-steroid induction therapy was prospectively evaluated in transplant-ineligible patients with multiple myeloma. After induction, patients were randomly assigned to maintenance treatment with lenalidomide a …

Citation

ID: 111019
Ref Key: s2020haematologicalenalidomide-based
Use this key to autocite in SciMatic or Thesis Manager

References

Blockchain Verification

Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
111019
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
5/5
Creates 1,000,000 NFT tokens for this article
Token Features:
  • ERC-1155 Standard NFT
  • 1 Million Supply per Article
  • Transferable via MetaMask
  • Permanent Blockchain Record
Blockchain QR Code
Scan with Saymatik Web3.0 Wallet

Saymatik Web3.0 Wallet